65 related articles for article (PubMed ID: 8621896)
21. Effects of the HIV-1 protein Tat on myocardial function and response to endotoxin.
McDonough KH; Doumen C; Giaimo M; Prakash O
Cardiovasc Toxicol; 2010 Dec; 10(4):250-8. PubMed ID: 20721641
[TBL] [Abstract][Full Text] [Related]
22. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
23. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
24. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat.
Caselli E; Betti M; Grossi MP; Balboni PG; Rossi C; Boarini C; Cafaro A; Barbanti-Brodano G; Ensoli B; Caputo A
J Immunol; 1999 May; 162(9):5631-8. PubMed ID: 10228047
[TBL] [Abstract][Full Text] [Related]
25. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
[TBL] [Abstract][Full Text] [Related]
26. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines.
Philippon V; Vellutini C; Gambarelli D; Harkiss G; Arbuthnott G; Metzger D; Roubin R; Filippi P
Virology; 1994 Dec; 205(2):519-29. PubMed ID: 7526541
[TBL] [Abstract][Full Text] [Related]
27. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.
Vogel J; Hinrichs SH; Reynolds RK; Luciw PA; Jay G
Nature; 1988 Oct; 335(6191):606-11. PubMed ID: 2845275
[TBL] [Abstract][Full Text] [Related]
28. Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice.
Brady HJ; Abraham DJ; Pennington DJ; Miles CG; Jenkins S; Dzierzak EA
J Virol; 1995 Dec; 69(12):7622-9. PubMed ID: 7494270
[TBL] [Abstract][Full Text] [Related]
29. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene.
Vellutini C; Horschowski N; Philippon V; Gambarelli D; Nave KA; Filippi P
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):21-9. PubMed ID: 7537511
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice.
Choi J; Liu RM; Kundu RK; Sangiorgi F; Wu W; Maxson R; Forman HJ
J Biol Chem; 2000 Feb; 275(5):3693-8. PubMed ID: 10652368
[TBL] [Abstract][Full Text] [Related]
31. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma.
Kundu RK; Sangiorgi F; Wu LY; Pattengale PK; Hinton DR; Gill PS; Maxson R
Blood; 1999 Jul; 94(1):275-82. PubMed ID: 10381523
[TBL] [Abstract][Full Text] [Related]
32. Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
Fitting S; Scoggins KL; Xu R; Dever SM; Knapp PE; Dewey WL; Hauser KF
Eur J Pharmacol; 2012 Aug; 689(1-3):96-103. PubMed ID: 22659585
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 tat acts as a growth factor and induces angiogenic activity in BK virus/tat transgenic mice.
Barbanti-Brodano G; Sampaolesi R; Campioni D; Lazzarin L; Altavilla G; Possati L; Masiello L; Benelli R; Albini A; Corallini A
Antibiot Chemother (1971); 1994; 46():88-101. PubMed ID: 7529977
[No Abstract] [Full Text] [Related]
34. B cell lymphoma in HIV transgenic mice.
Curreli S; Krishnan S; Reitz M; Lunardi-Iskandar Y; Lafferty MK; Garzino-Demo A; Zella D; Gallo RC; Bryant J
Retrovirology; 2013 Aug; 10():92. PubMed ID: 23985023
[TBL] [Abstract][Full Text] [Related]
35. AIDS virus bred in mice.
Hemenway CG
Dent Today; 1989 Mar; 8(2):10, 12. PubMed ID: 2597385
[No Abstract] [Full Text] [Related]
36. Involvement of TRPM7 in Alcohol-Induced Damage of the Blood-Brain Barrier in the Presence of HIV Viral Proteins.
Mack ML; Huang W; Chang SL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768230
[TBL] [Abstract][Full Text] [Related]
37. The role of HIV Tat protein in HIV-related cardiovascular diseases.
Jiang Y; Chai L; Fasae MB; Bai Y
J Transl Med; 2018 May; 16(1):121. PubMed ID: 29739413
[TBL] [Abstract][Full Text] [Related]
38. Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.
Langford D; Oh Kim B; Zou W; Fan Y; Rahimain P; Liu Y; He JJ
J Neurovirol; 2018 Apr; 24(2):168-179. PubMed ID: 29143286
[TBL] [Abstract][Full Text] [Related]
39. Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.
Jaeger LB; Nath A
Dis Model Mech; 2012 May; 5(3):313-22. PubMed ID: 22563057
[TBL] [Abstract][Full Text] [Related]
40. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.
Zhang JX; Diehl GE; Littman DR
PLoS One; 2008 Apr; 3(4):e2035. PubMed ID: 18446227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
